Search Results - "Ghulam Muhammad, A K M"
-
1
Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial
Published in PloS one (11-06-2010)“…Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional…”
Get full text
Journal Article -
2
HMGB1 mediates endogenous TLR2 activation and brain tumor regression
Published in PLoS medicine (01-01-2009)“…Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor that carries a 5-y survival rate of 5%. Attempts at eliciting a clinically relevant…”
Get full text
Journal Article -
3
High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity
Published in Journal of Virology (01-05-2008)“…Erratum ( vol. 82 , p. 6087 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
Get full text
Journal Article -
4
Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
Published in Clinical cancer research (01-07-2009)“…Purpose: In preparation for a phase I clinical trial using a combined cytotoxic/immunotherapeutic strategy with adenoviruses (Ad) expressing Flt3L (Ad-Flt3L)…”
Get full text
Journal Article -
5
Gene therapy and targeted toxins for glioma
Published in Current gene therapy (01-06-2011)“…The most common primary brain tumor in adults is glioblastoma. These tumors are highly invasive and aggressive with a mean survival time of 15-18 months from…”
Get more information
Journal Article -
6
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma
Published in Toxicology and applied pharmacology (01-05-2013)“…Adenoviral vectors (Ads) are promising gene delivery vehicles due to their high transduction efficiency; however, their clinical usefulness has been hampered…”
Get full text
Journal Article -
7
Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen
Published in Molecular therapy (01-10-2011)“…Glioblastoma multiforme (GBM) is a primary brain tumor with a median survival of 14.6 months postdiagnosis. The infiltrative nature of GBM prevents complete…”
Get full text
Journal Article -
8
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Published in Neuron (Cambridge, Mass.) (21-07-2021)“…C9orf72 repeat expansions cause inherited amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) and result in both loss of C9orf72 protein…”
Get full text
Journal Article -
9
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial
Published in Human gene therapy. Part B. Methods (01-08-2012)“…Adenoviral vectors (Ads) have been evaluated in clinical trials for glioma. However, systemic immunity against the vectors can hamper therapeutic efficacy. We…”
Get more information
Journal Article -
10
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
Published in Neurotherapeutics (01-10-2012)“…Immune-mediated gene therapy using adenovirus expressing Flt3 ligand and thymidine kinase followed by ganciclovir administration (Flt3/TK) effectively elicits…”
Get full text
Journal Article -
11
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
Published in Clinical cancer research (01-10-2009)“…Purpose: Glioblastoma multiforme is a deadly primary brain cancer. Because the tumor kills due to recurrences, we tested the hypothesis that a new treatment…”
Get full text
Journal Article -
12
Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
Published in Neoplasia (New York, N.Y.) (01-08-2012)“…Abstract Adenovirus-mediated delivery of the immune-stimulatory cytokine Flt3L and the conditionally cytotoxic thymidine kinase (TK) induces tumor regression…”
Get full text
Journal Article -
13
Giant cell type of primary intracranial malignant fibrous histiocytoma: a case report
Published in Brain tumor pathology (01-04-2006)“…The primary intracranial giant cell type of malignant fibrous histiocytoma (GC-MFH) is rare, and the resemblance to meningioma causes diagnostic confusion…”
Get full text
Journal Article -
14
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors
Published in Discovery medicine (01-10-2010)“…Glioblastoma multiforme (GBM) is a deadly primary brain tumor in adults, with a median survival of ~12-18 months post-diagnosis. Despite recent advances in…”
Get more information
Journal Article -
15
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2007)“…Expression of the immune-stimulatory molecule Fms-like tyrosine kinase 3 ligand (Flt3L) and the conditional cytotoxic enzyme herpes simplex virus type 1…”
Get full text
Journal Article -
16
Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization
Published in Brain tumor pathology (01-02-2000)“…Frozen sections of 35 astrocytic tumors of various histologic malignancies were analyzed by comparative genomic hybridization in an attempt to characterize the…”
Get full text
Journal Article -
17
Chromosome 22q Allelic Losses at Microsatellite Loci in Human Astrocytic Tumors
Published in Neurologia medico-chirurgica (1997)“…Common regions of deletion(s) on chromosome 22q and the correlations between loss of heterozygosity and patient survival were analyzed in 19 deoxyribonucleic…”
Get full text
Journal Article -
18
Ultrastructural changes of the vascular endothelium after intra-arterial administration of tumor necrosis factor-alpha (TNFα) in rat gliomas
Published in Journal of neuro-oncology (2000)“…The ensuing ultrastructural changes in tumor vascular endothelial cells following intra-arterial administration of tumor necrosis factor-alpha (TNFalpha) were…”
Get full text
Journal Article -
19
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model
Published in Neuro-oncology (Charlottesville, Va.) (01-02-2008)“…The disseminated characteristics of human glioblastoma multiforme (GBM) make it a particularly difficult tumor to treat with long-term efficacy. Most…”
Get full text
Journal Article -
20
Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor–induced Behavioral Deficits
Published in Molecular therapy (01-04-2008)“…Glioblastoma multiforme (GBM) is an invasive and aggressive primary brain tumor which is associated with a dismal prognosis. We have earlier developed a…”
Get full text
Journal Article